MONTREAL, QC – The Canadian Alliance for Skills and Training in Life Sciences (CASTL) is excited to launch a series of one-day workshops designed to provide students with intensive, hands-on training… Read More
Eight of nine patients responding to the treatment, plus the encouraging safety data observed in the RESOLVE Phase 1b/2a trial of EP-104GI, provided the catalyst for the trial expansion Early… Read More
Adds first-in-class investigational asset, NX-13, to AbbVie’s pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn’s disease (CD) NORTH CHICAGO, IL… Read More
First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC – Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery… Read More
The BMC is thrilled to announce that our CEO, Isabelle Caron, is one of the three remarkable graduates honored with the 2024 Prix Rayonnement by the Fondation. The candidates for… Read More
